What is it about?
This paper drives home the point that targeted and contextualized interventions are key to improving the quality of life of cancer survivors.
Featured Image
Why is it important?
This review underscores a critical role of innovative ways to conduct more global randomized-controlled clinical trials using tools that are inclusive of pain relevant domains such as pain screening and management.
Perspectives
Despite increasing survivorship globally, cancer pain remains undertreated. This means that a fair proportion of survivors continue to have poor quality of life as a result of undertreated cancer pain.Various studies have examined these differences and provide some guidance on prescriptive interventions. However, inconsistencies in study quality, design, settings and outcomes, provide no clear consensus on standardized strategies and expected outcomes From a global perspective, few studies have comprehensively examined the landscape of evidence-based practices for cancer pain treatment. The goal of this study was to appraise the quality and state of global cancer pain management and cancer pain outcomes across Africa, Europe and North America.
Charles Odonkor
Johns Hopkins University
Read the Original
This page is a summary of: Global cancer pain management: a systematic review comparing trials in Africa, Europe and North America, Pain Management, July 2017, Future Medicine,
DOI: 10.2217/pmt-2016-0047.
You can read the full text:
Contributors
The following have contributed to this page
